Imiquimod is a caspase 3 activator which acts as an immunomodulator and displays antiviral and anti-tumor activity. It is a patient-applied cream used for the treatment of genital warts and basal cell carcinoma.
This report contains market size and forecasts of Imiquimod in global, including the following market information:
Global Imiquimod Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Imiquimod Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Imiquimod companies in 2021 (%)
The global Imiquimod market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Imiquimod include Merck, TCI, Bio-Techne, Thermo Fisher Scientific, Santa Cruz Biotechnology, Cayman Chemical, Spectrum Chemical, LGC and BioVision, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Imiquimod manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Imiquimod Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Imiquimod Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Imiquimod Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Imiquimod Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Imiquimod Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Imiquimod Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Imiquimod revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Imiquimod revenues share in global market, 2021 (%)
Key companies Imiquimod sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Imiquimod sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
TCI
Bio-Techne
Thermo Fisher Scientific
Santa Cruz Biotechnology
Cayman Chemical
Spectrum Chemical
LGC
BioVision
Abcam
Selleck Chemicals
Enzo Biochem
AG Scientific
Cato Research Chemicals
Sinopaharrm Chemical Reagent